Skip to content

Medical-device intelligence

Abbott: selected FDA company records

Connect selected Abbott source names with their classification, clearance, and recall histories.

Included source names

Membership is based on Abbott Laboratories, 2025 Form 10-K, Exhibit 21 ↗, as of Jan 31, 2026. Mapping checked Nov 19, 2026. This is a selected research group, not a complete corporate family or a statement of current ownership.

  • Abbott Laboratories
  • Abbott Diabetes Care Inc.
  • Abbott Point of Care Inc.
  • Abbott Cardiovascular Systems Inc.
  • Abbott Molecular Inc.
  • Abbott Vascular Inc.

Matching FDA profiles

Names without a matching profile contribute no records. Punctuation and case are normalized; legal-name variants and private customer aliases are not merged automatically. Each underlying record is counted once.

Record activity in this scope

978 clearance records and 344 recall records in the covered releases, across 5 source company names and 318 product codes. Dated history runs from Sep 16, 1976 to Sep 23, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202505
December 202500
January 202600
February 202600
March 202600
April 202613
May 202600
June 202620
July 202600
August 202600
September 202610
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

1,322 matching records
Device / recordCompany in FDA recordSourceSource date
GLP systems TrackK213486 · JGSAbbott Laboratories510(k)Mar 10, 2022FDA decision date
Alinity m Integrated Reaction Units (IRU)Z-0710-2022 · OOIAbbott Molecular, Inc.RecallMar 2, 2022FDA record creation date
Alinity m System, Part No. 08N53-002Z-0460-2022 · MZPAbbott Molecular, Inc.RecallJan 6, 2022FDA record creation date
Alinity m System, Part No. 08N53-002Z-0461-2022 · MZPAbbott Molecular, Inc.RecallJan 6, 2022FDA record creation date
Alinity m System, Part No. 08N53-002Z-0462-2022 · MZPAbbott Molecular, Inc.RecallJan 6, 2022FDA record creation date
Alinity m System, Part No. 08N53-002Z-0463-2022 · MZPAbbott Molecular, Inc.RecallJan 6, 2022FDA record creation date
FreeStyle Libre 2 Flash Glucose Monitoring System (with FreeStyle Libre 2 App)K210943 · QLGAbbott Diabetes Care, Inc.510(k)Nov 22, 2021FDA decision date
ARCHITECT i1000SR REF 01L86-01/1L86 and 1L87; ARCHITECT i2000SR REF 03M74-02/3M74; ARCHITECT i2000 REF 08C89-01/1G17 and 8C89Z-0271-2022 · JJEAbbott LaboratoriesRecallNov 19, 2021FDA record creation date
ARCHITECT c4000 REF 02P24-01/2P24, 1P86, 1R24, and 1R25; ARCHITECT c8000 REF 01G06-11/1G06; ARCHITECT c16000 REF 03L77-01/3L77;Z-0272-2022 · JJEAbbott LaboratoriesRecallNov 19, 2021FDA record creation date
Alinity m SARS-CoV-2 Amp Kit (Emergency Use Authorization, US Assay) and Alinity m SARS-CoV-2 Application Specification File. in vitro diagnosti…Z-0004-2022 · QJRAbbott Molecular, Inc.RecallOct 14, 2021FDA classification date
Alinity m Resp-4-Plex AMP Kit (Emergency Use Authorization, US Assay) and Alinity m Resp-4-Plex Application Specification File. in vitro diagnost…Z-0005-2022 · QJRAbbott Molecular, Inc.RecallOct 14, 2021FDA classification date
Alinity m SARS-CoV-2 Amp Kit (Non-US Assay) and Alinity m SARS-CoV-2 Application Specification File. in vitro diagnosticZ-0006-2022 · QJRAbbott Molecular, Inc.RecallOct 14, 2021FDA classification date
Alinity m SARS-CoV-2 Amp Kit (Non-US Assay) and Alinity m SARS-CoV-2 Application Specification File. in vitro diagnosticZ-0007-2022 · QJRAbbott Molecular, Inc.RecallOct 14, 2021FDA classification date
Alinity m Resp-4-Plex AMP Kit (Non-US Assay) and Alinity m Resp-4-Plex Application Specification File. in vitro diagnosticZ-0008-2022 · QJRAbbott Molecular, Inc.RecallOct 14, 2021FDA classification date
Vysis CLL FISH Probe Kit with the following components: Vysis LSI p53 SpectrumOrange/ATM, SpectrumGreen and LSI D13S319, SpectrumOrange/ 13q34, S…Z-2576-2021 · OVQAbbott Molecular, Inc.RecallSep 27, 2021FDA record creation date
Alinity ci-series System Control Module clinical chemistry and immunoassay analyzer for in vitro diagnostic use. Model number LN 03R70-01Z-2472-2021 · JJEAbbott LaboratoriesRecallSep 14, 2021FDA record creation date
i-STAT CHEM8+ cartridge with the i-STAT 1 SystemK210958 · CGAAbbott Point of Care, Inc.510(k)Aug 13, 2021FDA decision date
FreeStyle Libre 2 Flash Glucose Monitoring SystemK211102 · QLGAbbott Diabetes Care, Inc.510(k)Aug 11, 2021FDA decision date
REF: 08P1820, Abbott Alinity c Activated Alanine Aminotransferase reagent Kit, Alinity c Activated Alanine Aminotransferase Reagent Kit,, IVD, C…Z-2184-2021 · CKAAbbott LaboratoriesRecallAug 2, 2021FDA record creation date
REF 8L92-22, Abbott Activated Alanine aminotransferase, for use with Architect, IVD, CE, UDI: (01) 00380740161859Z-2185-2021 · CKAAbbott LaboratoriesRecallAug 2, 2021FDA record creation date
REF 8L92-21, Abbott Activated Alanine Aminotransferase, for use with Architect, IVD, CE, UDI: (01) 00380740017866Z-2186-2021 · CKAAbbott LaboratoriesRecallAug 2, 2021FDA record creation date
REF 8L92-42, Abbott Activated Alanine Aminotransferase, for use with Architect, IVD, CE, UDI: (01) 00380740161866Z-2187-2021 · CKAAbbott LaboratoriesRecallAug 2, 2021FDA record creation date
FreeStyle Libre 2 Flash Glucose Monitoring System (with FreeStyle Libre 2 App)K201761 · QLGAbbott Diabetes Care, Inc.510(k)Jul 30, 2021FDA decision date
Abbott i-STAT CG8+ cartridges - IVD Intended for quantitative measurement of sodium, potassium, ionized calcium, glucose, pH, pCO2, pO2 and hemat…Z-0880-2021 · CHLAbbott Point Of Care Inc.RecallJan 19, 2021FDA record creation date
Abbott i-STAT EG7+ cartridge-IVD. Intended for the quantitative measurement of sodium, potassium, ionized calcium, pH, pCO2, pO2 and hematocrit …Z-0881-2021 · CHLAbbott Point Of Care Inc.RecallJan 19, 2021FDA record creation date
Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗